Gartner predicted four years a big decrease in Net Promoter Score use as a CX metric in 2025. But it's hanging around. In 2021, Gartner made a bold prediction: “More than 75% of organizations will ...
Nine years after Sarepta Therapeutics’ Exondys 51 won a controversial FDA approval to treat a subset of patients with Duchenne muscular dystrophy (DMD), a challenger from Massachusetts biotech Dyne ...
What if you could flip a genetic switch to silence a gene, then turn it back on with a simple drug? For researchers, gene-switch tools offer that kind of control—and a new system called Cyclone may ...
Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of any gene in a cell. Such "gene-switch" tools allow scientists to "turn on" ...
Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer. If you have been diagnosed with NSCLC, your health care provider may test your cancer to see if it has certain genetic ...
A man was allegedly drunk when he rear-ended another vehicle in Apple Valley late Saturday, Sept. 20, killing a man and injuring another, authorities said. The crash took place about 11:35 p.m. along ...
Aug 21 (Reuters) - Motorsport's governing body announced on Thursday a tender process to replace Red Bull and German investment company KW25 as commercial rights holders of the World Rally ...
July 7, 2025 – The FDA has granted quick approval to a first-of-its-kind pill for a type of lung cancer known as non-small-cell lung cancer (NSCLC). The drug, called sunvozertinib and sold as Zegfrovy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback